Effect of GP19 Peptide Hyperimmune Antiserum on Activated Macrophage during Ehrlichia canis Infection in Canine Macrophage-like Cells

SIMPLE SUMMARY: The commercial canine ehrlichiosis vaccine is still not available. A limitation of developing vaccines is the knowledge of the humoral immune response against E. canis infection is still unknown. In this study, we designed the peptide vaccine candidate, namely GP19(4-43), for inducin...

Descripción completa

Detalles Bibliográficos
Autores principales: Nambooppha, Boondarika, Rittipornlertrak, Amarin, Muenthaisong, Anucha, Koonyosying, Pongpisid, Tangtrongsup, Sahatchai, Tiwananthagorn, Saruda, Chung, Yang-Tsung, Sthitmatee, Nattawooti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388390/
https://www.ncbi.nlm.nih.gov/pubmed/34438767
http://dx.doi.org/10.3390/ani11082310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388390/
https://www.ncbi.nlm.nih.gov/pubmed/34438767
http://dx.doi.org/10.3390/ani11082310

Ejemplares similares